$83.48−0.91 (−1.08%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$83.03−0.45 (−0.54%)
After hours: Nov 17, 2026, 7:52 PM ET
Zoetis (ZTS) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~5.0%/yr (FY21→FY25), net margin 28.2%, and free cash flow (~$2.3B) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Returns vs FCF (181%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲2.3%
9,467.0
FY21→FY25CAGR +5.0%/yr
Net income ($M)▲7.5%
2,673.0
FY21→FY25CAGR +7.0%/yr
Free cash flow ($M)▼0.7%
2,283.0
FY21→FY25CAGR +7.1%/yr
Diluted EPS▲10.1%
6.02
buyback-liftedCAGR +9.0%/yr
What the receipts whisper · what a headline number hides
Share count
−6.9%
476.7mn → 443.8mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$621.0M
steady at 6.6% of revenue (−5.2% YoY).
Returns vs FCF
181%
$4.1B returned vs $2.3B of FCF in FY25. The gap comes off the balance sheet (see net cash).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
28¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 70.4% → 71.8%. Net margin 28.2% is more than double the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 9,494.0 | 9,467.0 | 9,256.0 | 8,544.0 | 8,080.0 | 7,776.0 | ▲2.3% | +5.0% |
Cost of revenue | 2,699.0 | 2,666.0 | 2,719.0 | 2,561.0 | 2,454.0 | 2,303.0 | ▼1.9% | +3.7% |
Gross profit | 6,795.0 | 6,801.0 | 6,537.0 | 5,983.0 | 5,626.0 | 5,473.0 | ▲4.0% | +5.6% |
Research & development | 722.0 | 698.0 | 686.0 | 614.0 | 539.0 | 508.0 | ▲1.7% | +8.3% |
Selling, general & admin | 2,370.0 | 2,378.0 | 2,318.0 | 2,151.0 | 2,009.0 | 2,001.0 | ▲2.6% | +4.4% |
Total operating expenses | 3,375.0 | 3,255.0 | 3,198.0 | 2,967.0 | 2,709.0 | 2,713.0 | ▲1.8% | +4.7% |
Operating incomefeeds ROC rank | 3,420.0 | 3,546.0 | 3,339.0 | 3,016.0 | 2,917.0 | 2,760.0 | ▲6.2% | +6.5% |
Other income, net | −278.0 | −186.0 | −206.0 | −80.0 | −261.0 | −272.0 | — | — |
Pretax income | 3,142.0 | 3,360.0 | 3,133.0 | 2,936.0 | 2,656.0 | 2,488.0 | ▲7.2% | +7.8% |
Income tax | 635.0 | 687.0 | 637.0 | 596.0 | 545.0 | 454.0 | ▲7.8% | +10.9% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 2,507.0 | 2,673.0 | 2,486.0 | 2,344.0 | 2,114.0 | 2,037.0 | ▲7.5% | +7.0% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 5.93 | 6.02 | 5.47 | 5.07 | 4.49 | 4.27 | ▲10.1% | +9.0% |
Diluted shares (mn) | 411.60 | 443.83 | 454.85 | 462.27 | 470.38 | 476.72 | ▼2.4% | −1.8% |
| Margins | ||||||||
Gross margin60th pct in Healthcare | 71.6% | 71.8% | 70.6% | 70.0% | 69.6% | 70.4% | ▲1.2pp | +1.5pp |
Operating margin | 36.0% | 37.5% | 36.1% | 35.3% | 36.1% | 35.5% | ▲1.4pp | +2.0pp |
Net margin91st pct in Healthcare | 26.4% | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | ▲1.4pp | +2.0pp |
† TTM = trailing four quarters through 2026-09-30.
5 more years of statements and CSV export are on Premium, and 10 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-12 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Zoetis' revenue last fiscal year?
Zoetis reported revenue of $9,467.0M in fiscal 2025, up 2.3% from fiscal 2024.
What was Zoetis' net income?
Zoetis reported net income of $2,673.0M in fiscal 2025, a net margin of 28.2%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

